PLASMAPHERESIS, RITUXIMAB AND LOW-DOSE CYCLOPHOSPHAMIDE FOR REMISSION INDUCTION THERAPY IN SEVERE ANCA-ASSOCIATED VASCULITIS

被引：0
|
作者：
Gulati, Kavita [1 ]
McAdoo, Stephen [1 ]
Galliford, Jack [1 ]
Griffith, Megan [1 ]
Levy, Jeremy [1 ]
Cairns, Tom [1 ]
Pusey, Charles [1 ]
机构：
[1] Imperial Coll London, Renal & Vasc Inflammat Sect, London, England
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
FP159
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A SINGLE CENTER RETROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY BETWEEN LOW-DOSE VERSUS HIGH-DOSE RITUXIMAB AS REMISSION INDUCTION THERAPY IN JAPANESE PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Hirose, Kei
    Hirata, Manami
    Yamamura, Yuriko
    Ueno, Akiko
    Yamamura, Masahiro
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1756 - 1756
  • [32] Single dose of rituximab for ANCA-associated vasculitis
    Nature Reviews Rheumatology, 2014, 10 (5) : 258 - 258
  • [33] Safety Of Remission Induction With Rituximab Versus Cyclosphosphamide In Patients 65 and Older With Severe ANCA-Associated Vasculitis
    Miloslavsky, Eli
    Specks, Ulrich
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert F.
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Tchao, Nadia
    Ding, Linna
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Stone, John H.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S313 - S313
  • [34] ANCA Response upon Rituximab or Cyclophosphamide in ANCA-associated Vasculitis Patients
    van Dam, Laura
    Dirikgil, Ebru
    Bredewold, Edwin
    Ray, Argho
    Rabelink, Ton
    van Kooten, Cees
    Teng, Onno
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [35] Rituximab maintenance therapy in ANCA-associated vasculitis
    Lorenz, Judith
    AKTUELLE RHEUMATOLOGIE, 2024, 49 (05) : 281 - 281
  • [36] THE EFFECT OF CYCLOPHOSPHAMIDE AND RITUXIMAB FOR REMISSION INDUCTION AND MAINTENANCE IN SEVERE ANCA-ASSOCIATED VASCULITIS ON IMMUNOGLOBULIN LEVELS: REPEAT CYCLES ON CLINICAL RELAPSE WITH RITUXIMAB ARE ASSOCIATED WITH STABLE IGA AND IGG
    Yusof, M. Y. Md
    Porto, M. -I.
    Andrews, J.
    Dass, S.
    Savic, S.
    Vital, E. M.
    Emery, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 161 - 162
  • [37] Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab and Remission Induction in ANCA-Associated Vasculitis
    Jayne, David R. W.
    Merkel, Peter A.
    Bekker, Pirow
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (15): : 1535 - 1535
  • [38] Correspondence on 'Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis'
    Parikh, Akshay
    Devarasetti, Phani Kumar
    Rajasekhar, Liza
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (01)
  • [39] THE EFFECT OF REDUCED-DOSE ORAL GLUCOCORTICOIDS DURING INDUCTION OF REMISSION INDUCTION IN SEVERE ANCA-ASSOCIATED VASCULITIS
    Walsh, Michael
    Merkel, Peter
    Jayne, David
    RHEUMATOLOGY, 2019, 58
  • [40] Rituximab Versus Cyclophosphamide for ANCA-Associated Vasculitis with Renal Involvement
    Geetha, Duvuru
    Specks, Ulrich
    Stone, John H.
    Merkel, Peter A.
    Seo, Philip
    Spiera, Robert
    Langford, Carol A.
    Hoffman, Gary S.
    Kallenberg, Cees G. M.
    St Clair, E. William
    Fessler, Barri J.
    Ding, Linna
    Tchao, Nadia K.
    Ikle, David
    Jepson, Brett
    Brunetta, Paul
    Fervenza, Fernando C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (04): : 976 - 985
12345